| MEDIF Stock | | | USD 0.05 0 4.17% |
This module uses fundamental data of Medipharm Labs to approximate its Piotroski F score. Medipharm Labs F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of Medipharm Labs Corp. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about Medipharm Labs financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medipharm Labs Corp. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as
signals in gross domestic product.
At this time, it appears that Medipharm Labs' Piotroski F Score is Unavailable. Although some professional money managers and academia have recently criticized
Piotroski F-Score model, we still consider it an effective method of
predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
0.0
Piotroski F Score - Unavailable
| Change in Return on Assets | |
| Cash Flow Return on Assets | |
| Current Quality of Earnings (accrual) | |
| Long Term Debt Over Assets Change | |
| Change In Outstending Shares | |
Medipharm Labs Piotroski F Score Drivers
The critical factor to consider when applying the Piotroski F Score to Medipharm Labs is to make sure Medipharm is not a subject of accounting manipulations and runs a healthy internal audit department. So, if Medipharm Labs' auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if Medipharm Labs' financial numbers are properly reported.
About Medipharm Labs Piotroski F Score
F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled
Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.
About Medipharm Labs Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medipharm Labs Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medipharm Labs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at
the intrinsic value of Medipharm Labs Corp based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing
financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our
fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Medipharm OTC Stock
Medipharm Labs financial ratios help investors to determine whether Medipharm OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medipharm with respect to the benefits of owning Medipharm Labs security.